The efficacious delivery of eukaryotic expression plasmids to inductive cells of the immune system constitutes a key prerequisite for the generation of effective DNA vaccines. Here, we have explored the use of bacteria as vehicles to orally deliver expression plasmids. Attenuated Salmonella typhimurium aroA harbouring eukaryotic expression plasmids that encoded virulence factors of Listeria monocytogenes were administered orally to BALB/c mice. Strong cytotoxic and helper T cell responses as well as antibody production were elicited even after a single administration. Mice immunised four times with Salmonella that carried a eukaryotic expression plasmid encoding the secretory listerial protein listeriolysin were protected against a subsequent lethal challenge with this pathogen. A single dose was already partially protective. The efficiency of this vaccination procedure was due to transfer of the expression plasmid from the bacterial carrier to the mammalian host. Evidence for such an event could be obtained in vivo and in vitro. Expression of the desired antigen in various lymphoid tissues was already detectable 1 day after administration of the DNA vaccine and persisted for at least 1 month in spleen and mesenteric lymph nodes. Induction of cytotoxic and helper T cell responses was observed in all mouse strains tested including outbred strains whereas antibodies were mainly detected in BALB/c. Furthermore, we could show that immunogenicity could be improved by increasing the invasiveness of the bacterial carrier. ß
Introduction
The rational development of vaccines is one of the major challenges of medicine and biology. This requires on the one hand an understanding of the physiology of the particular pathogen or of a pathogenic situation in which the search for suitable antigens is to be carried out, and subsequently the delivery of such antigens in an appropriate way so as to induce protective immune reactions. On the other hand, with the increasing knowledge of the workings of the immune system and its dysfunctions, in particular of the immunobiology of the cells involved in the generation of an immune response, it should now be feasible to devise speci¢c immunotherapies for infectious and autoimmune diseases, and allergies. All of these situations will require the development of individual vaccine strategies suitable for each particular problem.
Genetic vaccination, i.e. immunisation with an isolated eukaryotic expression plasmid that encodes the antigen rather than immunisation with the antigen itself, has added a new dimension to vaccine research [1, 2] . The tremendous £exibility o¡ered by DNA vaccination includes the possibility of co-expressing immunomodulatory molecules like cytokines, co-stimulatory molecules or antisense RNA to steer the immune response into the required direction. In addition, antigens can be manipulated by addition of sequences that target transport to particular cellular compartments or in£uence their processing, thus improving the e¤cacy of immunisation. Furthermore, DNA vaccines can be applied in ways that favour either systemic or mucosal responses. Thus, it is foreseeable that appropriate expression plasmids for a wide variety of applications will be developed that allow a rapid testing of potential protective vaccine candidates in suitable animal models and a quick assessment of optimal strategies.
A major drawback of genetic vaccination is its ine¤-ciency, which is inherent in the way that vaccines are currently delivered, and its requirement of relatively large amounts of puri¢ed plasmids [2] . Thus, it is mandatory to develop carrier systems that improve e¤cacy and possibly also target the vaccines to in vivo inductive sites and cells of the immune system. The use of bacteria as vehicles for genetic vaccination is an attractive and simple idea that derives from a number of intrinsic properties a¡orded by these systems. Bacteria are the workhorses of molecular biologists and studies on a multitude of bacterial species have revealed detailed information as to how these bacteria can invade virtually any eukaryotic cell type. Many of these bacteria display regional tropisms often manifested as colonisation of speci¢c mucosal surfaces or internal organs. Thus bacteria that target inductive cells of the immune system are highly attractive candidates for vaccine delivery and have in the past been developed as live vehicles for inducing protective responses to a wide variety of heterologously expressed antigens [3^5] . In this respect, bacteria-based delivery systems would o¡er several advantages over currently used viral vectors [6, 7] . Many viral vectors have been shown to be ine¡ective in priming immune responses [8] . Viral proteins encode immunodominant epitopes which compete with epitopes of the recombinant protein for inducing T cells. In addition, the amount of additional DNA that can be cloned into bacterial plasmids is several orders of magnitude larger than the current viral vectors can accommodate. Furthermore, bacteria are controllable by common antibiotics thus adding additional safety features to these carriers. Finally, it should be possible to produce bacterial DNA carriers at low costs and to apply such vaccines orally. Thus, we decided to use Salmonella typhimurium as a carrier for oral genetic vaccination [9] since such bacteria have widely been used as antigen carriers, they can be easily handled in the laboratory and several well characterised attenuated strains are available [10, 11] .
Materials and methods

Bacterial strains
S. typhimurium aroA (SL7237) was kindly provided by Dr B.A.D. Stocker and grown in LB medium supplemented with additional NaCl when indicated. Bacteria were incubated overnight at 37³C with shaking at maximum 50 rpm until an OD 600 of 0.6 was reached, then washed and resuspended in 5% bicarbonate for oral administration or phosphate-bu¡ered saline (PBS) for nasal application. Listeria monocytogenes EGD was grown in BHI broth.
Mice
Six^8-week-old female mice from Harlan (Borchem) were used for all experiments. Mice were selected for different resistance to S. 
Immunisation procedure
Oral administration was achieved by feeding 30 Wl containing 10 8 bacteria to mice that were deprived of drinking water for 1 or 2 h. Nasal application was carried out on anaesthetised animals by applying 20 Wl bacterial suspension containing 5U10 5 Salmonella to each nostril. These doses were titrated before to assure e¤ciency without overt e¡ects.
Molecular biological procedures
These procedures were done as described [9] . The eukaryotic expression vectors were based on pCMVL purchased from Clontech. LacZ was replaced by truncated genes encoding either listeriolysin (LLO) or ActA. The constitutive prokaryotic expression in the Salmonella carrier was achieved by using the pAH97 vector containing the Pr and Ps promoter of the xylS gene from Pseudomonas putida into which lacZ was introduced.
Cellular immunological procedures
Induction of CD4 and CD8 was analysed by cytotoxic and helper T cell assays, respectively. Brie£y, for CD8 responses, T cells from immunised animals were isolated from spleen and co-cultured for 4 
Kinetics of antigen expression
Mice were orally immunised with recombinant Salmonella pCMVL and Peyers Patches, mesenteric lymph nodes and spleen were excised at di¡erent time points. Cells were suspended in IMDM/10% foetal calf serum (FCS) and cocultured after irradiation (4000 Rad) with L galactosidase (L gal) speci¢c CD4 or CD8 T cell lines at ratios of stimulators to responder of 10:1. Responses were determined by measuring thymidine incorporation after 3 days of coculture.
Enzyme-linked immunosorbent assay (ELISA)
Plates were coated with 0.5 Wg ml 31 of puri¢ed protein in PBS overnight at 4³C. After washing, sera were added at 1:100 dilution in PBS containing 0.2% Tween 20 and incubated for 2 h at 37³C. Binding was revealed by using peroxidase-conjugated anti-mouse Ig and OPD as substrate. Colour reaction was measured at 490 nm. For comparison, samples were tested on the same plate. Thus, our results should be compared only within one experiment. Collection of samples: serum was collected by obtaining blood from the tail artery or by cardiac puncture after sacri¢ce. Saliva: mice injected with 200 Wg ml 31 of Pillocarpin (Sigma). Saliva was collected using a micro pipette and after addition of protease inhibitor was kept at 370³C until tested for antibody content. For the collection of lung and intestinal lavage, tissue was washed with 1^2 ml of PBS containing 0.5% FCS and 5 mM EDTA. Into the intestinal lavage, protease inhibitor was added. Then solutions were centrifuged and supernatants were stored at 370³C until use.
Results
E¤cient induction of immune response with DNA vaccines orally delivered by Salmonella
The basic hypothesis was that when eukaryotic expression plasmid-bearing S. typhimurium aroA were fed to BALB/c mice, the transformants would cross the gut epithelium via M cells [12] . In the Peyers Patches, they would then be phagocytosed by macrophages and dendritic cells where the bacteria would die due to the attenuation and release their plasmids. This would transfect the host cells and lead to antigen expression. At the same time, the phagocytic cells would be activated due to the endotoxins of the bacterial carrier and therefore e¤ciently induce cytotoxic T cells which in turn would lyse the phagocytes. Release of antigen would subsequently induce helper T cells and antibody production. Thus, all of the speci¢c arms of the immune system should be induced. Fig. 1 shows that this was indeed the case. In mice that were immunised with Salmonella transformants that carried expression plasmids encoding either LLO, a secretory protein of L. monocytogenes, or ActA, a membrane protein of L. monocytogenes, cytotoxic and helper T cells as well as antibody production could be detected. Surprisingly, a single administration was su¤cient to induce a good response that could be improved to some extent by multiple administrations.
To test whether such vaccination would result in an immune response that would confer protection against a lethal infection with a pathogenic microorganism, we immunised mice with the recombinant Salmonella as above and challenged them with a dose of L. monocytogenes corresponding to 10ULD 50 . Mice that had received multiple administrations of transformants harbouring a LLO expression plasmid were completely protected (Table 1) . Even a single administration of such transformants protected most of the mice. Surprisingly, transformants carrying the expression plasmid encoding the membrane protein ActA did not protect the mice although a good immune response was induced. This is most likely due to the fact that ActA is not available to the processing mechanisms for MHC class I and class II presentation as long as the bacteria are viable [13, 14] . Thus ActA is not a protective antigen although immune responses can be detected against this protein when the infection is cleared by the animals [13] . Fig. 1 . Induction of immune responses after single or multiple oral immunisations with S. typhimurium harbouring an eukaryotic expression plasmid that encoded either LLO or ActA [13] . Groups of mice were immunised once or four times at 2-week intervals with 10 8 recombinant S. typhimurium aroA, a strain that is unable to synthesise aromatic amino acids. Cytotoxic and helper T cells from spleen and serum antibodies were analysed 11 weeks after the ¢rst administration. Cytotoxicity : T cells were restimulated in vitro and tested after 5 days at an E:T ratio of 50:1 in the JAM assay [35] using as targets PHem 3.3 cells (P815 expressing LLO) [36] or P815 that were sensitised using LLO-mediated introduction of soluble ActA into the cytosol [37, 38] . Helper T cells: soluble puri¢ed proteins were added to spleen cell cultures and proliferation was assessed by incorporation of radioactive thymidine after 3 days. Antibodies : ELISAs were performed on plates coated with puri¢ed proteins.
Evidence for DNA transfer from the bacterial carrier to the host
In order to substantiate our hypothesis about the immunisation route, it was necessary to exclude the possibility that the e¤cient immune response observed after administration of transformants carrying eukaryotic expression plasmids was due to residual protein expression in the bacterial carrier itself. Therefore, we compared the responses after oral administration of the same number of transformants containing either an eukaryotic expression plasmid encoding L gal or a plasmid expressing L gal under the control of a prokaryotic promoter. When induction of cytotoxic cells was tested, it was found that a single administration of the transformant with eukaryotic expression vector, where DNA transfer must take place, was far superior to multiple administrations of a transformant where the protein is produced by the carrier itself (Fig. 2) . A single dose of the latter transformants did not result in a measurable response. The di¡erence was even more dramatic for the induction of helper T cells and antibodies. Under these conditions, only transformants with the eukaryotic expression plasmids induced a response whereas no helper T cells or antibodies could be detected even after multiple immunisations with the carrier itself expressing the protein. This suggests that in vivo transfer of expression plasmids is needed for e¤cient induction of immune reactions.
Direct evidence for DNA transfer was obtained in vitro. Primary peritoneal macrophages were infected with transformants that carried eukaryotic expression plasmid encoding L gal and tested for enzymatic activity. Activity could be detected only after overnight incubation of cells but not shortly after termination of the infection. This indicates that su¤cient time must be allowed for the DNA transfer to take place. In addition, in such infected/transfected macrophages, it was possible by reverse transcription-PCR to detect splice products that were derived from splice donors and acceptors placed immediately upstream of the coding region of L gal in the expression plasmid. Furthermore, translation of L gal was observed in such macrophages even in the presence of tetracycline, an antibiotic which blocks bacterial protein synthesis without interfering with translation by the host cell (data not shown). Interestingly, such Salmonella-mediated transfection could so far only be observed with primary macrophages. Established phagocytic cell lines were refractory to this procedure (data not shown). Fig. 2 . Comparison of immune responses induced by S. typhimurium carrying either a eukaryotic (pCMVL) or a prokaryotic (pAH97) [39] expression plasmid encoding L gal. Groups of mice were immunised with recombinant S. typhimurium aroA once or four times at 2-week intervals and tested 7 weeks after the ¢rst administration as described in Fig. 1 using P13 .1 (P815 expressing L gal) [40] as targets and puri¢ed L gal for stimulation of helper T cells and to coat ELISA plates. 
Induction of memory responses by Salmonella-mediated oral DNA vaccination
The e¤ciency of induction of T cells and antibodies, and in particular the observation that even a single dose results in an almost maximal response, renders Salmonellamediated oral DNA vaccination a very promising way of genetic immunisation provided a long lasting immunological memory is induced. To test this, mice were immunised once or four times with Salmonella bearing plasmids that encoded L gal under the control of either a eukaryotic or a prokaryotic promoter. Mice were analysed for antibodies and T cell responses 8 months after administration of the single dose or 6 months after the fourth dose (Fig. 3) . No speci¢c antibodies could be detected in these mice although shortly after vaccination such antibodies had been present in mice immunised with Salmonella carrying the eukaryotic, but not the prokaryotic, expression plasmid.
Nevertheless, speci¢c cytotoxic activity after in vitro restimulation could be detected at both 6 and 8 months following multiple and single immunisations, respectively, in mice immunised with the Salmonella harbouring the eukaryotic expression plasmid. No cytotoxicity could be measured when spleen cells from such mice were tested directly ex vivo or when cells were derived from mice immunised with Salmonella carrying the prokaryotic expression plasmid. Interestingly, multiple administrations of the latter did induce a measurable response when tested shortly after immunisation (mice were derived from a parallel group of the experiments described above). Similarly, cytotoxic activity has always been detected ex vivo when mice that had received Salmonella with eukaryotic expression plasmids were tested shortly after immunisation. This suggests that mice which had received Salmonella with eukaryotic expression plasmids contained high numbers of cytotoxic T cells. However, these could only be detected after restimulation in vitro. The strong proliferative response of the spleen cells from the same mice suggested the presence of a large number of helper T cells. Thus, Salmonella-mediated oral DNA vaccination induces a long lasting immunological memory. Again, a single dose was su¤cient to elicit a near maximum response.
In£uence of growth conditions on immunisation e¤ciency
The transmigration of M cells by Salmonella is an active process which requires the induction of genes encoded by so-called pathogenicity islands. Such genes are strongly induced when Salmonella are grown under anaerobic conditions and high salt [15, 16] . To take this into consideration, cultures were always grown without aeration. In addition, invasiveness could be increased when additional NaCl was added to the broth. Recombinant bacteria expanded under such conditions exhibited a higher invasiveness for epithelial cells when tested in vitro. When bacteria Fig. 4 . In£uence of salt concentrations in the bacterial culture on humoral immune response induced by Salmonella-mediated oral DNA vaccination. Groups of mice were immunised with 10 8 recombinant S. typhimurium aroA carrying pCMVL that were grown in LB medium containing di¡erent concentrations of NaCl. ELISA was performed on serum samples taken 10 or 18 days after oral administration of the bacteria. Fig. 3 . Oral genetic vaccination induces long lasting T cell memory. Groups of mice were immunised once or four times at 2-week intervals with recombinant S. typhimurium aroA (see Fig. 2 ) and tested 6^8 months after the last administration for cytotoxicity and helper T cells (see Fig. 1 for methods).
grown under these conditions were employed as carrier for oral DNA vaccination, the immune response was also improved (Fig. 4) . Only antibody responses were measured in these experiments since this type of response turned out to be the best criterion for determining e¤cient induction of immune reactions. T cell responses were usually obtained even when immunisation conditions were not optimal (see below).
In£uence of the host genetic background on oral DNA vaccination using Salmonella as carrier
So far, experiments had been performed with mice of the BALB/c strain only. Since this strain is very susceptible to infection by S. typhimurium, it was important to extend the ¢ndings to strains which are more resistant such as C57Bl/6 or DBA/2 or even outbred mice like NIH Swiss [17^21]. Fig. 5 shows that T cell responses could be induced in all mouse strains tested. Although cytotoxicity was not analysed in outbred mice due to the lack of appropriate target cells, the presence of helper cells suggests that cytotoxic T cells should also be present in these mice. In contrast, none of the mice from these other strains produced speci¢c antibodies after receiving a single oral dose of recombinant Salmonella carrying an eukaryotic expression plasmid that always induced signi¢cant antibody responses in BALB/c. Thus, the genetic background and susceptibility to Salmonella play an important role for B cell responses but are negligible for T cell stimulation in our system.
Induction of systemic and local immune responses after oral DNA vaccination using Salmonella as carrier
Nasal vaccination is often superior to oral application and might result in a general mucosal immune reaction [22] . Therefore, we compared oral and nasal application of Salmonella harbouring an eukaryotic expression plasmid encoding L gal. Systemic T cell responses were induced by both routes although nasal application was clearly inferior to oral administration since multiple doses were required to obtain a signi¢cant response (Fig. 6) . 5 S. typhimurium aroA carrying pCMVL once or four times at 2-week intervals. Spleen cells were tested for L gal speci¢c cytotoxicity and helper T cells 7 weeks after the ¢rst administration as described in Fig. 1 . At the same time, serum and saliva as well as washes of lung and gut were collected and tested by ELISA. This might have been due to the lower number of bacteria that could be applied nasally due to toxicity of the bacteria under these circumstances.
Total antibodies speci¢c for L gal were also determined from serum, lung lavage, saliva and the gut lumen. As demonstrated in Fig. 6 , vaccination via both routes induced systemic antibodies whereas the occurrence of mucosal antibody was speci¢c to the route of application, i.e. oral administration induced antibodies in the gut and not in the lung and nasal administration induced antibodies in the lung but not in the gut. This seems to re£ect the property of Salmonella to remain only a short time in the mucosa-associated lymphoid tissue and to quickly disseminate into the deep organs such as spleen and liver [23] .
To test this hypothesis, it was important to monitor where and when the DNA transfer from the bacterial carrier to the host cells takes place. Therefore, mice were vaccinated with Salmonella containing an eukaryotic expression plasmid that encoded L gal and then cells from Peyers Patches, spleen and mesenteric lymph nodes were tested for antigen presenting capacity to speci¢c CD4 and CD8 T cell lines. As demonstrated in Fig. 7 , antigen presentation could readily be measured in all organs between day 1 and day 2 after administration of the vaccine and the peak was reached by 7 days. After 1 month, spleen and lymph node cells still had a detectable stimulatory capacity while cells from Peyers Patches showed only a weak stimulatory capacity. No bacteria could be detected at any time in mice immunised in such a way. The fact that antigen is presented for at least a month after a single dose of the vaccine most likely explains the strong response that is observed under these circumstances.
Discussion
Several bacterial species have been shown to be able to transfer eukaryotic expression plasmids into host cells. Shigella £exneri, Listeria monocytogenes and recombinant Escherichia coli that harbour the invasion plasmid of Shigella have been used successfully [24^27]. Since these bacteria escape from the phagosome, it has been postulated that entry into of the cytosol would be a crucial step in bacteria-mediated transfection. However, data with S. typhimurium presented here and accumulating data with other bacteria [28, 29] clearly show that expression plasmids can be transferred from the carrier to the nucleus of a host cell without the bacteria leaving the vacuole. The mechanism of DNA transfer is currently poorly understood and may depend on properties inherent to the bacteria and the cell type in use. Thus, in vitro DNA transfer by S. typhimurium was only observed with primary macrophages whereas recombinant E. coli that were unable to leave the vacuole could also transfer DNA into established cell lines [9, 28] .
Evidence for DNA transfer by bacteria in vivo has been obtained by using bacteria as carrier for genetic vaccination. Using attenuated strains of S. £exneri and Salmonella typhi as DNA carrier, antibody responses against the transgene could be detected in mice [29, 30] . However, due to the availability of a well established murine infection model, detailed data were obtained mainly with attenuated S. typhimurium [9] . It could be demonstrated that oral vaccination with such bacteria induces speci¢c cytotoxic and helper T cells in various mouse strains and protects them against a lethal challenge with the pathogenic bacteria L. monocytogenes provided a protective antigen was used as transgene (see below). Similar protection has been obtained in a tumour model using L gal as a surrogate tumour speci¢c antigen [31] . Speci¢c antibodies could also be induced in this system, however, this required the correct genetic background since an antibody response was only reproducibly detected in BALB/c mice. This response might be dose dependent. The higher resistance of Fig. 7 . Kinetics of antigen expression in antigen presenting cells from di¡erent lymphoid tissues after Salmonella-mediated oral genetic vaccination. Cells from Peyers Patches (PP), mesenteric lymph nodes (LN) and spleen (SP) were isolated at various times from mice that had received orally 10 8 Salmonella harbouring an eukaryotic expression plasmid for L gal and were tested for supporting the growth of a CD4 and a CD8 T cell line speci¢c for L gal.
other strains of mice to S. typhimurium [17^21] could result in less bacteria present in the animals, thus lower plasmid transfer and thus lower amounts of antigen expressed. A similar reason might be that upon infection with S. typhimurium, IFNQ is induced in all mouse strains except in BALB/c [32, 33] . IFNQ is known to down-regulate viral promoters like the one used in our studies and thus could cause down-regulation of antigen expression [34] . These hypotheses are currently being tested.
A single oral administration of the vaccine was found to induce a response that is close to the maximum response obtained with multiple administration. Analysing the kinetics of appearance of cells presenting the antigen after DNA transfer revealed that they are present mainly in spleen and lymph nodes for a considerable length of time. Since after being activated by the bacterial carrier these cells are most likely also equipped with the necessary co-stimulatory molecules, this could explain the e¤cacy of the vaccination. It also explains why the response is mainly systemic. Under these circumstances, transfer is either taking place mainly in lymph nodes and spleen or presenting cells migrate to these organs after DNA transfer early in the Peyers Patches.
It was surprising that immunity against the listerial membrane protein ActA did not protect the mice against a lethal dose of L. monocytogenes while immunity against the secretory protein LLO did. Subsequent studies revealed that ActA was not presented either by MHC class I or class II molecules as long as the bacteria were viable [13] . Consistent with this ¢nding is the observation that cytotoxic T cells against ActA could be demonstrated in mice infected with sublethal doses of L. monocytogenes only late in infection when most of the bacteria had already been eliminated from the animal [13] . However, when ActA was secreted from these bacteria as a recombinant protein, it was presented to CD8 as well as to CD4 T cells and could serve as a protective antigen [13] . Killing the bacteria inside the presenting cells with antibiotics also quickly rendered this membrane protein presentable by MHC class I [13] . If these ¢ndings can be generalised, questions need to be raised as to the potential of bacterial and protozoal membrane proteins as vaccine candidates. On the other hand, it amply demonstrates the potential of bacteria-mediated DNA vaccination since assessment of such potential vaccine candidates could easily be carried out in appropriate animal models simply based on DNA sequence information. Taking into account the rapid accumulation of whole genome sequences of pathogenic organisms, it is obvious that such tools will be of extreme importance in future vaccine development.
Increasing invasiveness by slightly changing the growth conditions of the recombinant bacteria resulted in a stronger immune response. By extrapolation, it should be possible to select variant strains of the bacterial carrier that constitutively exhibit this property. A similar approach should be possible for improvement of the mucosal component of this type of vaccination. Thus, in parallel with improvements of the expression plasmids in the future, it should be possible to tailor the bacterial carrier according to the particular vaccination problem. In addition, compared to conventional genetic immunisation using isolated plasmid DNA, the bacterial carrier adds simplicity of handling and speci¢c targeting to inductive sites and cells of the immune system.
